Table 3.
Variable | Unmatched | Propensity Score Matched | ||
---|---|---|---|---|
Before Accreditation | After Accreditation | Before Accreditation | After Accreditation | |
MACE | ||||
Crude HR (95% CI) | 1.00 | 0.79 (0.68–0.9) | 1.00 | 0.85 (0.74–0.98) |
P value | 0.001 | 0.029 | ||
Age‐ and sex‐adjusted HR (95% CI) | 1.00 | 0.75 (0.65–0.86) | 1.00 | 0.81 (0.7–0.94) |
P value | <0.001 | 0.006 | ||
Multivariate adjusted HR (95% CI)a | 1.00 | 0.77 (0.67–0.88) | 1.00 | 0.78 (0.68–0.91) |
P value | <0.001 | 0.001 | ||
All‐cause death | ||||
Crude HR (95% CI) | 1.00 | 0.67 (0.49–0.91) | 1.00 | 0.67 (0.48–0.93) |
P value | 0.011 | 0.017 | ||
Age‐ and sex‐adjusted HR (95% CI) | 1.00 | 0.64 (0.47–0.88) | 1.00 | 0.64 (0.46–0.89) |
P value | 0.005 | 0.009 | ||
Multivariate‐adjusted HR (95% CI)a | 1.00 | 0.69 (0.5–0.95) | 1.00 | 0.71 (0.51–0.99) |
P value | 0.022 | 0.042 |
HR indicates hazard ratio; MACE, major adverse cardiovascular events; MI, myocardial infarction.
Adjusted for age, sex, the level of the city where the hospital is located, first medical contact site or not, comorbidities including smoking status, diabetes mellitus, hypertension, dyslipidemia, diabetes mellitus, heart failure history, renal failure history, previous MI, previous percutaneous coronary intervention or coronary artery bypass grafting, type of MI, Killip classes, preadmission use of aspirin, preadmission use of P2Y12 receptor inhibitors, and preadmission use of statins.